Hologic has announced FDA 510(k) clearance and CE marking for its Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays, designed to rapidly detect common bacterial causes of infectious gastroenteritis. The fully automated molecular tests address a significant diagnostic challenge in clinical microbiology laboratories.
Los Angeles-based EntroGen, Inc. has launched a PCR-based Microsatellite Instability (MSI) Detection Kit designed for research use, targeting laboratories equipped with standard qPCR instrumentation. The assay offers a streamlined approach to detecting MSI, a molecular signature present in a subset of colorectal cancers.
Thermo Fisher Scientific has launched the Gibco Expi293 PRO Expression System, a next-generation HEK293-based platform engineered to address persistent challenges in producing difficult-to-express proteins for therapeutic development and structural biology research.
Chronic kidney disease (CKD) affects more than 850 million individuals worldwide and represents a major public health challenge. Despite its high prevalence, CKD is frequently underdiagnosed due to its asymptomatic nature and slow progression. Early detection is essential to prevent irreversible kidney damage and improve clinical outcomes. Urinary albumin is one of several markers used […]
TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.
Roche has unveiled results from its comprehensive TSIX Study Program evaluating a new high-sensitivity cardiac troponin T assay designed to improve acute myocardial infarction diagnosis in emergency settings. The sixth-generation test, recently granted CE Mark approval, demonstrates significant advances in sensitivity and accuracy for detecting cardiac events.
Takara Bio Europe has introduced Cellartis® MSC EV Wonder™, a chemically defined, xeno-free culture medium designed to address scalability challenges in mesenchymal stem cell-derived extracellular vesicle (MSC-EV) manufacturing. The product targets researchers developing cell-free therapeutic candidates for regenerative medicine and immunomodulation applications.
SynGenSys has introduced NK.SET™, the first commercially available synthetic promoter library designed specifically for natural killer (NK) cell immunotherapies. The Sheffield-based biotechnology company’s announce-ment marks a significant validation of its platform for engineering tissue-specific gene regulation control elements.
Bio-Rad launches consolidated specialty immunoassay quality control in Europe Bio-Rad Laboratories has introduced its Specialty Immunoassay Plus (SPIA Plus) control system to European clinical laboratories, offering enhanced quality monitoring capabilities for specialty immunoassay testing procedures.
Amsbio has launched an expanded portfolio of ready-to-use, sterile cell lines designed to accelerate CAR-T cell therapy research for leukaemia treatment. The offering addresses growing demand for standardised cellular tools following the 2017 FDA approval of CAR-T therapy for children and adolescents with B cell acute lymphoblastic leukaemia (ALL).
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
